Convalescent Plasma to Stem Coronavirus in COVID negative participants (CSSC-001)Research Question:
Does blood plasma from people who are recovered from COVID-19 infection help prevent
COVID-19 infection when given to others?
Basic Study Information
Purpose:Location: University of Rochester
This study will determine if plasma collected from the blood of people who have recovered
from COVID-19 infection will help others who are at risk for getting COVID-19. Participants
should be people who are at high risk for COVID-19 infection. They will receive a
one-time infusion of plasma from a person who has recovered from a COVID-19 infection.
Plasma will not have COVID-19 but will have antibodies to the virus. The purpose
of this study is to determine if these antibodies will help keep people who are at
high risk for getting COVID from getting infected. To be eligible you must have had
close contact with someone who is COVID-19 positive and have a high risk for illness
such as >=65, reside in a nursing home or long-term care facility, have chronic lung
disease, asthma, heart disease, obesite, uncontrolled diabetes, renal failure, liver
disease or cancer. Or you must be a healthcare professional with high risk exposure
such as have had prolonged close contact with patients with COVID-19 who were not
wearing a facemask while HCP nose and mouth were exposed to material potentially infectious
with the virus causing COVID-19.
Study Reference #: 4964
Lead Researcher (Principal Investigator)
Study Contact InformationStudy Coordinator: Susanne Heininger
Phone: (585) 273-1926
Additional Study Details
Number of Visits:
2 to 5
Trial Not Found
The study you are looking for is not active at this time.
Return to Search